Cargando…
Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis
The c-Jun-N-terminal kinase (JNK) is a critical mediator involved in various physiological processes, such as immune responses, and the pathogenesis of various diseases, including autoimmune disorders. JNK is one of the crucial downstream signaling molecules of various immune triggers, mainly proinf...
Autores principales: | Lai, Benjamin, Wu, Chien-Hsiang, Lai, Jenn-Haung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696795/ https://www.ncbi.nlm.nih.gov/pubmed/33198301 http://dx.doi.org/10.3390/cells9112466 |
Ejemplares similares
-
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis
por: Bagnoud, Maud, et al.
Publicado: (2020) -
Ferroptosis and Autoimmune Diseases
por: Lai, Benjamin, et al.
Publicado: (2022) -
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
por: Lai, Jenn-Haung, et al.
Publicado: (2019) -
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016) -
c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases
por: Hepp Rehfeldt, Stephanie Cristine, et al.
Publicado: (2020)